Increasing challenges to trial recruitment: Is it time to change the inclusion criteria for investigational compounds, not just for study participants?

Amit David Eyal, Sara Eyal*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Original languageAmerican English
JournalEpilepsia
DOIs
StateAccepted/In press - 2024

Keywords

  • candidate screening
  • clinical trials
  • desirability score
  • drug design
  • structure–activity relationships

Cite this